Search

OMS-103HP

OMS103HP is the first drug being developed to improve joint function following arthroscopic surgery, one of the most common procedures performed today by orthopedic surgeons.

Allogenic Human Umbilical Derived Mesenchymal Stem Cells in Conditioned Media

The condition medium (CM) derived from these MSCs has also been implicated in therapeutic properties. … In comparison to bone-marrow derived MSCs, these cells are more resilient, easier to extract, and generally regarded as less immunogenic.

Distigmine

Distigmine is available in several countries as a treatment of underactive detrusor and voiding dysfunction in the urinary tract where the active ingredient is distigmine bromide. … It improves detrusor function thereby restoring normal voiding patterns in patients suffering from detrusor underactivity [A27176].

Medetomidine

In the United States, it is currently approved for its veterinary use in dogs and distributed by Pfizer Animal Health. In Canada, medetomidine is distributed by Novartis Animal Health. … Medetomidine is an intravenously available alpha-2 adrenergic agonist. The drug has been developed by Orion Pharma.

Stamulumab

MYO-029 is a human anti-GDF-8 monoclonal antibody, which is being developed to treat muscle-wasting diseases including muscular dystrophy and age-related sarcopenia.

BNC105

Chikungunya virus Senegal strain 37997 capsid protein

One of three components of a recombinant Chikungunya virus vaccine called Vimkunya.

Chikungunya virus Senegal strain 37997 envelope protein E2

One of three components of a recombinant Chikungunya virus vaccine called Vimkunya.

Butyrylcholinesterase

Benzoctamine

It can also be used as an anxiolytic with the same efficacy as chlordiazepoxide for treating anxiety neurosis.